# Your CMS GUIDE Partner for Specialized Dementia Support

[Learn more](https://my.synapticure.com/)

# Author

## Danielle Geraldi-Samara, MD

**February 9, 2024**  
**Advancing Mental Health Care: Results from Synapticure’s Virtual Program**  
Early results from Synapticure’s mental healthcare program show real improvements in anxiety, depression, and caregiver support through telehealth. [Read more](/content/blog/advancing-mental-health-care-results-from-synapticures-virtual-program/index.html)

**February 9, 2024**  
**Synapticure on Science: Clinical Trials for Sporadic ALS**  
Summary of drug trials for sporadic ALS: qualifications, mechanisms of action, early-stage results, and FDA status. [Read more](/content/blog/als-clinical-trials-amyotrophic-gehrig-fda-nurown-tregs-drugs-biologics/index.html)

**February 9, 2024**  
**Synapticure on Science: Qualifying for and Choosing the Right ALS Clinical Trial**  
Synapticure prioritizes clinical trial discussions so you can make informed decisions about which trial is best for you. [Read more](/content/blog/als-clinical-trials-amyotrophic-lateral-sclerosis-gehrig-interventional-cder-cber-fda-placebo-qualifications-neuron-neuromuscular-neurodegenerative-neurology-telehealth-telemedicine/index.html)

**February 9, 2024**  
**Demystifying the Draw (Which blood tests are important for ALS?)**  
A look at the different blood tests that are drawn before diagnosing ALS and the reasons why we do them. [Read more](/content/blog/demystifying-the-draw/index.html)

**February 9, 2024**  
**Specialty Care and ALS**  
How specialists can help primary care physicians and clinics maintain their heroic patient care efforts for ALS patients. [Read more](/content/blog/specialty-care-and-als/index.html)

**February 9, 2024**  
**Layering Care for ALS patients**  
A look at how a virtual clinic optimizes a comprehensive care model for ALS patients. [Read more](/content/blog/layering-care-for-als-patients/index.html)

**February 9, 2024**  
**Tapping into a Lumbar Puncture**  
Step-by-step guide to lumbar punctures for a less scary experience. [Read more](/content/blog/tapping-into-a-lumbar-puncture/index.html)

**February 9, 2024**  
**Shedding Light on the Sunshine Vitamin and ALS**  
Many patients wonder about Vitamin D supplementation and ALS. Here is the scoop on this unique vitamin. [Read more](/content/blog/shedding-light-on-the-sunshine-vitamin-and-als/index.html)

**February 9, 2024**  
**Symptomatic Therapies for ALS**  
ALS patients should know of these modalities for symptomatic treatments to improve quality of life and function. [Read more](/content/blog/symptomatic-therapies-for-als/index.html)

**February 9, 2024**  
**Disease Modifying Therapy**  
A primer on where we stand with available FDA approved disease modifying treatment for ALS. [Read more](/content/blog/disease-modifying-therapy/index.html)

.avif)
**February 9, 2024**  
**More than Muscle: FTD and its Association with ALS**  
A glance at the cognitive disease Frontotemporal Dementia (FTD) which can underlie the motor symptoms of ALS. [Read more](/content/blog/more-than-muscle-ftd-and-its-association-with-als/index.html)

**February 9, 2024**  
**Clinical Constellations**  
A look at the different faces of ALS. [Read more](/content/blog/clinical-constellations/index.html)

**February 9, 2024**  
**Creating Calm**  
How we can help tame anxiety, a common symptom associated with ALS. [Read more](/content/blog/creating-calm/index.html)

**February 9, 2024**  
**The Art of Partnership**  
Synapticure’s Dr. Danielle Geraldi explains how we work hand-in-hand with patients’ existing care teams. [Read more](/content/blog/the-art-of-partnership/index.html)

**February 9, 2024**  
**Your 25**  
Every stride we take towards slowing ALS progression is a step closer to the cure for patients with ALS. [Read more](/content/blog/your-25/index.html)

**February 9, 2024**  
**Primary Lateral Sclerosis (PLS)**  
Synapticure has opened its doors to those living with Primary Lateral Sclerosis (PLS). [Read more](/content/blog/synapticure-launches-to-serve-primary-lateral-sclerosis-patients/index.html)

**February 9, 2024**  
**Helping You Access Amylyx's New Drug, Relyvrio**  
The third FDA approved treatment for ALS, Relyvrio, is now open for enrollment and prescription. Here is a timeline of what you can expect in the coming weeks and how Synapticure can help you through the process. [Read more](/content/blog/helping-you-access-amylyxs-new-drug-relyvrio01/index.html)

**February 9, 2024**  
**A Win for AMX0035 - What does this mean for you?**  
A new therapy for ALS is on the horizon and here are the details! [Read more](/content/blog/a-win-for-amx0035/index.html)

.avif)
**February 9, 2024**  
**A Car and Mr. R**  
My journey as an ALS physician. [Read more](/content/blog/a-car-and-mr-r/index.html)